Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology ...

A Freemasons Lodge has made a “lasting impact” after donating £1,000 to the 1st Leverington Rainbows group. The donation from ...

GILD's industry had an average PEG ratio of 2.28 as of yesterday's close. The Medical - Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 79 ...

Civil society group Sankalp Rehabilitation Trust had opposed Gilead’s patent application on the grounds that it was a known compound. The twice-a-year injectable has generated much interest ...

A new study reveals that two yearly injections of the drug lenacapavir is more effective at preventing HIV than a daily pill ...

Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil fumarate 300mg.

The published belrestotug/dostarlimab data is still too immature to prove the combination’s capability to disrupt the NSCLC ...

Raymond James has recently raised Gilead Sciences, Inc. (GILD) stock to Outperform rating, as announced on July 8, 2024, according to Finviz. Earlier, on May 1, 2024, Maxim Group had reiterated the ...

Two years ago, a few friends who regularly met at the Speckled Paw in Mt. Gilead formed a group called the Dollar Club. This ...